Literature DB >> 7948099

Mutations of two lysine residues in the CDR loops of a recombinant immunotoxin that reduce its sensitivity to chemical derivatization.

I Benhar1, U Brinkmann, K O Webber, I Pastan.   

Abstract

B3(Fv)-PE38 is a recombinant single-chain immunotoxin in which the Fv region of monoclonal antibody B3 is connected to a truncated form of Pseudomonas exotoxin. It would be desirable to use the lysine residues of the molecule for chemical modification so that it can be derivatized with poly(ethylene glycol) to achieve reduced immunogenicity or with the Bolton-Hunter reagent for biodistribution studies. We found that derivatizing lysine residues of B3(Fv)-PE38 causes a marked loss of specific target cell cytotoxicity and/or immunoreactivity. Here we show that two lysine residues in the antibody-combining region of B3(Fv)-PE38 can be replaced with arginines, with only a small loss of cytotoxicity and no change in specificity. This mutant molecule is 3-fold more resistant to inactivation by derivatization with succinimidyl 4-(N-maleimidomethyl)cyclohexane 1-carboxylate (SMCC) or Bolton-Hunter reagent.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7948099     DOI: 10.1021/bc00028a007

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  3 in total

1.  Targeting antibacterial agents by using drug-carrying filamentous bacteriophages.

Authors:  Iftach Yacoby; Marina Shamis; Hagit Bar; Doron Shabat; Itai Benhar
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

2.  Covalent disulfide-linked anti-CEA diabody allows site-specific conjugation and radiolabeling for tumor targeting applications.

Authors:  Tove Olafsen; Chia-Wei Cheung; Paul J Yazaki; Lin Li; Gobalakrishnan Sundaresan; Sanjiv S Gambhir; Mark A Sherman; Lawrence E Williams; John E Shively; Andrew A Raubitschek; Anna M Wu
Journal:  Protein Eng Des Sel       Date:  2004-01       Impact factor: 1.650

3.  Rapid humanization of the Fv of monoclonal antibody B3 by using framework exchange of the recombinant immunotoxin B3(Fv)-PE38.

Authors:  I Benhar; E A Padlan; S H Jung; B Lee; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 12.779

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.